子分类：
| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 1 | Extract solution and herbal mixture for treatment of hepatitis | US498699 | 1995-07-03 | US5648089A | 1997-07-15 | Tarek Shawkat |
| A newly formulated herbal mixture and herbal nasal drops are provided for ethical use and treatment of vital hepatitis diseases. The herbal formulation is in two parts, which may be used separately or together, including (1) an oral herbal formulation including coarse granules of 9 herbs, ground and added together in specific ratios; and (2) nasal drops prepared from the extract of a single herb, namely Ecballium Elaterium A. Rich. | ||||||
| 2 | Hair and skin cosmetic and conditioner | US1200360 | 1960-03-01 | US3133864A | 1964-05-19 | YOSHIHIDE HAGIWARA |
| 3 | Processes for products from lotus | US825660 | 1986-01-31 | US4929467A | 1990-05-29 | Karen M. Slimak |
| A variety of different food products, prepared from lotus, arrowhead and buckbean varieties of the families Nymphaeaceae, Alismateceae and Gentianaceae, is substituted for wheat and other grains, milk, eggs, and a partial substitute for nuts. | ||||||
| 4 | Process for producing harringtonine and homoharringtonine | US50852 | 1987-05-14 | US4783454A | 1988-11-08 | Yaguang Liu |
| A new pharmaceutical composition for treating nonlymphatic leukemia, such as granulocytic and monocytic leukemia comprising Harringtonine, Homoharringtonine, Anethole, Oleanolic acid and Ginsenoside and method of making the same. | ||||||
| 5 | Safe antileukemia drug, SAL | US737949 | 1985-05-28 | US4675318A | 1987-06-23 | Yaguang Liu |
| A new pharmaceutical composition for treating nonlymphatic leukemia, such as granulocytic and monocytic leukemia comprising Harringtonine, Homoharringtonine, Anethole, Oleanolic acid and Ginsenoside and method of making the same. | ||||||
| 6 | Ayurvedic composition for the prophylaxis and treatment of AIDS, flu, TB and other immuno-deficiencies and the process for preparing the same | US304902 | 1994-09-13 | US5529778A | 1996-06-25 | Surendra Rohatgi |
| An ayurvedic composition for prophylaxis and treatment of AIDS, flu, TB, and other immuno-deficiency conditions, and for liver diseases such as hepatitis and sclerosis, includes prescribed doses of extracts or isolates of two multi-component drugs in selected proportions. The first multi-component drug, LIVZON, consists of Phyllanthus niruri (292-310 mg.), Tinospora cordifolia (190-210 mg.), Phyllanthus emblica (90-110 mg.), Terminalia belerica (90-110 mg.), and Terminalia chebula (290-310 mg.); and the second multi-component drug, IMMINEX, consists of Holarrhena antidysenterica (40-60 mg.), Picrorhiza kurrooa (40-60 mg.), and Swertia chirata (15-35 mg.). The beneficial composition may be administered in the form of aqueous extracts, hard gelatin capsules, or mixed with syrup. The process of making the composition requires the basic ingredients to be cleaned, washed, dried and separated from all extraneous matter, after which they are powdered and extracts obtained therefrom with distilled water. The extracted material may be concentrated, granulated and dried at low temperature before the various ingredients are mixed in their selected proportions to form the necessary pharmaceutical dosage. Hard gelatin capsules or a syrup are other optional forms for dispensing the composition to patients. | ||||||
| 7 | Medicinal agent and method for treatment of mastitis in animals and humans | US384175 | 1989-07-21 | US5061491A | 1991-10-29 | Alexandr M. Deryabin |
| A medicinal agent for treatment of mastitis in animals and humans which includes a mixture of a decoction of a mixture of the following medicinal herbs in equal parts by weight and an ammonia solution infusion which is a mixture of the same medicinal herbs in equal parts by weight, wherein the medicinal herbs include Matricaria chamomilla L., flores Calendulae officinalis L., Urtica dioica L., Erythreae centaurium Raf. L., gemmae Betula pendula Roth, Plantago major L., gammae Pinus sylvestris L., Origanum vulgare L., Salvia officinalis Hoffm., Archangelica officinalis Hoffm., Taraxacum officinale Web., folium Tussilaginis farfarae L., Sanguisorba officinalis L., Valeriana officinalis L., Menthae piperitae L., Thymus vulgaris L., and Bidens tripartita L. The decoction and infusion are mixed in a ratio to adjust the Ph of the mixture to not below 7.4. Also disclosed is a method of treating mastitis using the medicinal agent described above. | ||||||
| 8 | Safe antileukemia drug, SAL | US62073 | 1987-05-14 | US4808629A | 1989-02-28 | Yaguang Liu |
| A new pharmaceutical composition for treating nonlymphatic leukemia, such as granulocytic and monocytic leukemia comprising Harringtonine, Homoharringtonine, Anethole, Oleanolic acid and Ginsenoside and method of making the same. | ||||||
| 9 | フラボン−６−Ｃ−グルコース誘導体を有効成分として含有する神経精神疾患治療又は予防用薬学的組成物 | JP2016534534 | 2014-08-14 | JP2016531909A | 2016-10-13 | フン リュ、ジョン; フン チョン、ジェ; ヨン シン、チャン; シク チャン、デ; ユン イ、ヒュン; ジ キム、ヒュン; リュ、ビョル |
| 【課題】フラボン−6−C−グルコース誘導体又はこれを含有する生薬抽出物を有効成分として含む薬学組成物又は食品組成物を提供する。【解決手段】本発明の組成物は、せん妄、認知症又は健忘症などの認知機能障害疾患、脳卒中、中風、集中力障害、不安障害又は睡眠障害を効果的に治療又は予防する作用効果を示す。【選択図】図1 | ||||||
| 10 | Hair growth promoting agent composition | JP2003543556 | 2001-09-28 | JP2005508997A | 2005-04-07 | ホ ジョン アン; スク ヨン チャン; セオング ロク ファン; イン ビョン ユン; ムーン ジョン ラン; ミン ホ リー |
| 【解決手段】本発明は毛髪成長促進剤組成物に関し、より詳しくは、本発明は５α−還元酵素活性抑制成分、細胞活性作用成分、及び末梢血管拡張成分を含んでなる。
【効果】本発明の毛髪成長促進剤組成物は優れた毛髪成長効果を有する。 |
||||||
| 11 | A medicament for the treatment of mastitis in animals and humans | JP50912789 | 1989-04-28 | JP2703083B2 | 1998-01-26 | アレクサンドル ミハイロビチ デリアビン |
| 12 | Swertia japonica herba extract and production thereof | JP17573985 | 1985-08-12 | JPS6236330A | 1987-02-17 | KURONO MASATSUNE; IIDA TAKASHI; KATO HIDEKAZU; YAMAKAWA HIDESHI; YAGI KUNIO |
| PURPOSE: To obtain the titled extract containing swertiamarin and oleanolic acid useful as a drug effect components, by extracting swertia japonica herba with ethanol in a specific concentration. CONSTITUTION: Swertia japonica herba is extracted with an aqueous solution of ethanol in 70W90vol% concentration in a volume of 6W20 times based on the weight of the dried swertia per extracting operation to give a sertia japonica herba extract containing ≥20mg swertiamarin based on 1g dried weight of the swertia japonica herba and ≥6mg oleanolic acid based on 1g dried weight of the swertia herba. Although the swertia japonica herba extract contains swertiamarin which is a water-soluble active constituent and oleanolic acid which is a water-insoluble active constituent in high contents, the composition of the extract components is changed depending on the kind or concentration of alcohol used as an extraction solvent. The use of the aqueous solution of the ethanol in the above-mentioned concentration provides the swertia japonica herba extract containing both active constituents. COPYRIGHT: (C)1987,JPO&Japio | ||||||
| 13 | Method for the treatment and prevention of mucositis | JP2009521373 | 2007-07-27 | JP5433415B2 | 2014-03-05 | エツィオ ボンバルデッリ、; パオロ モラッツォーニ、 |
| Disclosed is the use of an anthocyanoside and/or an aglycon thereof or extracts containing them to prepare topical or systemic medicinal products for the treatment of mucositis. Preferably, the anthocyanoside is cyanidin, delphinidin, pelargonidin, Proanthocyanidin A2 or B2 or an extract of Vaccinium myrtillus or Vitis vinifera . | ||||||
| 14 | Method for the treatment and prevention of mucositis | JP2009521373 | 2007-07-27 | JP2009544687A | 2009-12-17 | エツィオ ボンバルデッリ、; パオロ モラッツォーニ、 |
| 粘膜炎、特に化学療法剤または放射線療法と組み合わせた前記薬剤の投与後の粘膜炎を治療および予防する方法が本明細書で開示されている。 より具体的には、本明細書で開示されているものは、アントシアノサイド、プロアントシアニジンまたはアントシアノサイドもしくはプロアントシアニジンの少なくとも１つを含有する抽出物の少なくとも１つの治療有効量を粘膜炎の治療または予防のために投与することである。 治療有効量のアントシアノサイド、プロアントシアニジンまたは抽出物は、単独で、または抗炎症剤、免疫調節剤、鎮痛剤、抗菌剤もしくは抗真菌剤の少なくとも１つの治療有効量と組み合わせて投与し得る。 また本明細書で開示されるものは、粘膜炎を治療および予防するための医薬組成物でもある。 | ||||||
| 15 | Water-dispersible nanoparticle including blood circulation promoter | JP2007272386 | 2007-10-19 | JP2009096787A | 2009-05-07 | KANAZAWA KATSUHIKO |
| <P>PROBLEM TO BE SOLVED: To provide a nanoparticle including a blood circulation promoter and a biodegradable polymer, excellent in dispersion stability, safe, and having high transparency and good absorbability by virtue of a small particle diameter. <P>SOLUTION: The water-dispersible nanoparticle includes a blood circulation promoter and a biodegradable polymer, and the nanoparticle contains 0.1-100 wt.% blood circulation promoter based on the weight of the biodegradable polymer. <P>COPYRIGHT: (C)2009,JPO&INPIT | ||||||
| 16 | Kyansukora-Difuyusa containing pharmaceutical composition | JP2007537096 | 2005-10-21 | JP2008516997A | 2008-05-22 | バーテル，ミヒャエル |
| 本発明は、リンドウ科のＣａｎｓｃｏｒａ種の植物から得られる活性物質、特に、キャンスコラ・ディフューサ種の植物から得られる物質を含有する医薬組成物に関する。 本発明のＣａｎｓｃｏｒａ含有組成物は、種々の中枢神経系の障害、特に、集中障害や学習障害、登校困難、登校拒否、失読症、記憶遅滞、発達遅滞、言語発達遅滞、混乱状態、認知症、老人性認知症、アルツハイマー病、記憶障害、脆弱（Ｘ）症候群、精神病、うつ病、統合失調症、情動精神病、躁病、恐怖状態およびパニック状態、子供および大人の多動性行動、幻覚、強迫行為例えば洗浄強迫、異常行動、神経性食欲不振症、意欲欠如、境界線症候群、自閉症、双極性情動障害、知的障害、おびえ状態、悪夢、チック、自信欠陥を治療するために投与可能である。 | ||||||
| 17 | Hair lotion having improved properties in hair-protecting action, hair reduction-preventing action and action for lowering external action of androgenic alopecia and the resulting hair damage | JP2000021538 | 2000-01-31 | JP2000226317A | 2000-08-15 | CASADO GALCERA FRANCESC |
| PROBLEM TO BE SOLVED: To prepare a hair lotion capable of lowering an androgenic decalvant action to prevent the decrease of hair and induce and promote the growth of hair. SOLUTION: This hair lotion is prepared by adding a mixture as an active ingredient to an alcoholic or hydroalcoholic medium containing auxiliary ingredients, such as vitamins, colorants and aromatic agents, acceptable to cosmetics. The mixture as the active ingredient is obtained by mixing an extract (L) of Humulus lupulus, an extract (R) of Rosmarinus officinalis L., an extract (Sw) of Swertia japonica, and silanodiol salicylate (Ssi) in an amount ratio of L>R>Sw>Ssi. When the hair lotion is applied to the scalp of an androgenic alopecia patient according to an intensive treatment program for applying a prescribed dose of the hair lotion to the patient everyday for six weeks and to the subsequent maintenance program for applying the hair lotion every other day for two months, the reduction of hair can be prevented, and the growth of new hair can be confirmed. | ||||||
| 18 | Buckbean (Menyanthestrifoliata) how anti-aging composition comprising a leaf extract and its use | JP2009522912 | 2007-07-05 | JP2009545604A | 2009-12-24 | アントン，ロベール; ヴェニージェ，ベルナール; ア コースジェンス，ユゴー; セント，イルス; デクレルク，リエブ; ロブスタン，アンヌリーズ |
| ミツガシワ（Menyanthes trifoliata）の葉で同定される活性物質（ここで該活性物質は、MMP-1、2、及び9の1種以上の阻害物質である及び／又はペルオキシ亜硝酸の除去物質である）の皮膚有効量を含む老化防止組成物。 また、加齢による老化又は早期老化の徴候について皮膚を治療することを含む、そのような組成物を用いる方法も開示される。 | ||||||
| 19 | In the lowering of hair impairment caused extrinsic action of hair protective action and prevention of hair impairment and androgenetic alopecia as a result, hair lotion with improved properties | JP2000021538 | 2000-01-31 | JP4195763B2 | 2008-12-10 | カサド ガルセラ フランセスク |
| 20 | Antidiabetic composition, antidiabetic food, antidiabetic skin care preparation for external use, and antidiabetic agent | JP2004113027 | 2004-04-07 | JP2005298358A | 2005-10-27 | OGAWA HIROSHI; JOHAZAMA TOSHINORI |
| <P>PROBLEM TO BE SOLVED: To obtain an antidiabetic composition, to provide an antidiabetic food, to provide an antidiabetic skin care preparation for external use and to obtain an antidiabetic agent. <P>SOLUTION: The antidiabetic composition contains Hercampure. The antidiabetic composition has type II diabetes controlling action, serum lipid improving action, liver lipid improving action, serum glucose decreasing action, free fatty acid improving action, insulin resistance improving action, and cholesterol reducing action. The antidiabetic food, the antidiabetic skin care preparation for external use and antidiabetic agent contain the antidiabetic composition, respectively. <P>COPYRIGHT: (C)2006,JPO&NCIPI | ||||||
QQ群二维码
意见反馈
意见反馈